ArticleSaudi medical journal2020
Mapping COVID-19 related research from Saudi Arabia, a scoping review. Between reality and dreams.
Article in Saudi medical journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- An evaluation of pharmaceutical clinical trials from Saudi Arabia registered on Clinicaltrials.gov: A cross-sectional study.Saudi medical journal · 2025Article
- Pattern of pediatric emergency dental care during COVID-19 pandemic in Saudi Arabia.The Saudi dental journal · 2024Article
- An Unprecedented Experience: Personal and Socio-Political Impacts of the COVID-19 Lockdown in Saudi Arabia.Cureus · 2024Article
- COVID-19 infections, recoveries, and mortality: an ANOVA model of locations and administrative areas in Saudi Arabia.Frontiers in public health · 2024Review
- Article
- Coronavirus disease 2019 in proportion to population: a historical analysis of Saudi Arabia.Bulletin of the National Research Centre · 2022Article
- Characteristics and outcome of COVID-19 cases in Saudi Arabia: Review of six-months of data (March-August 2020).Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2021Article
- Perceptions towards COVID-19 and adoption of preventive measures among the public in Saudi Arabia: a cross sectional study.BMC public health · 2021Article
- Clinical Efficacy of Hydroxychloroquine in Patients with COVID-19: Findings from an Observational Comparative Study in Saudi Arabia.Antibiotics (Basel, Switzerland) · 2021Article
- Characteristics of First Cases of Coronavirus Disease 2019 and the Effort to Prevent the Early Spread of COVID-19 in Saudi Arabia.Risk management and healthcare policy · 2021Article
- Increased Emergency Calls during the COVID-19 Pandemic in Saudi Arabia: A National Retrospective Study.Healthcare (Basel, Switzerland) · 2020Article
- COVID-19 in Saudi Arabia: An Overview.Frontiers in public healthReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo map research production by Saudi-affiliated investigators in order to identify areas of strength and weakness. Method: We followed the Arksey and O'Malley (2005) framework. Medline and Cochrane databases were searched with a focus on identifying articles related to COVID-19 and Saudi Arabia following the PRISMA protocol. The study was conducted at King Saud University, Riyadh, Saudi Arabia between March and May 2020. Results: A total of 53 articles were ultimately included. Most of the research production from Saudi Arabia was opinion and narrative reviews related to the clinicopathological features of COVID-19 as well as control and prevention of virus spread. Conclusion: The results of this scoping review identify a relative deficiency in original research, which requires further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.